These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 3469158

  • 21. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D, O'Hare MD, Robbins MJ, Wall RA, Williams AH, Cremer AW, Ridgway GL, Grüneberg RN.
    Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.
    Texier-Maugein J, Mormède M, Fourche J, Bébéar C.
    Eur J Clin Microbiol; 1987 Oct; 6(5):584-6. PubMed ID: 3125050
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R, Griggs D, Andrews JM.
    Rev Infect Dis; 1988 Oct; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [Abstract] [Full Text] [Related]

  • 28. In-vitro activity of newer quinolones against aerobic bacteria.
    Auckenthaler R, Michéa-Hamzehpour M, Pechère JC.
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Sensitivity of 7 mycobacterial species to new quinolones].
    Gevaudan MJ, Mallet MN, Gulian C, Terriou P, Lagier P, de Micco P.
    Pathol Biol (Paris); 1988 May; 36(5):477-81. PubMed ID: 3136429
    [Abstract] [Full Text] [Related]

  • 31. Quantitative determination of ofloxacin, ciprofloxacin, norfloxacin and pefloxacin in serum by high pressure liquid chromatography.
    Groeneveld AJ, Brouwers JR.
    Pharm Weekbl Sci; 1986 Feb 21; 8(1):79-84. PubMed ID: 2938073
    [Abstract] [Full Text] [Related]

  • 32. In-vitro selection of bacteria resistant to the 4-quinolone agents.
    Limb DI, Dabbs DJ, Spencer RC.
    J Antimicrob Chemother; 1987 Jan 21; 19(1):65-71. PubMed ID: 3470281
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Husson MO, Izard D, Bryskier A, Leclerc H.
    Chemioterapia; 1985 Aug 21; 4(4):278-83. PubMed ID: 3863716
    [Abstract] [Full Text] [Related]

  • 35. Interaction between biofilms formed by Staphylococcus epidermidis and quinolones.
    Yassien M, Khardori N.
    Diagn Microbiol Infect Dis; 2001 Jul 21; 40(3):79-89. PubMed ID: 11502373
    [Abstract] [Full Text] [Related]

  • 36. Antibacterial activity of ofloxacin and other 4-quinolone derivatives: in-vitro and in-vivo comparison.
    Chantot JF, Bryskier A.
    J Antimicrob Chemother; 1985 Oct 21; 16(4):475-84. PubMed ID: 3864775
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].
    Habiyaremye I, Verbist L, Vandepitte J.
    Pathol Biol (Paris); 1987 Jun 21; 35(5 Pt 2):800-4. PubMed ID: 3116489
    [Abstract] [Full Text] [Related]

  • 39. Cytotoxicity and uptake of pefloxacin, ciprofloxacin, and ofloxacin in primary cultures of rat hepatocytes.
    Nordmann P, Pechinot A, Kazmierczak A.
    J Antimicrob Chemother; 1989 Sep 21; 24(3):355-63. PubMed ID: 2808191
    [Abstract] [Full Text] [Related]

  • 40. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
    Ridgway GL, O'Hare MD, Felmingham D, Grüneberg RN.
    Drugs Exp Clin Res; 1985 Sep 21; 11(4):259-62. PubMed ID: 2941258
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.